|
Delayed
NSE India S.E.
06:05:25 05/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 94.65 INR | +3.05% |
|
+10.38% | -14.03% |
Company Valuation: Quest Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 |
|---|---|---|
| Market Cap 1 | 1,679 | 1,711 |
| Change | - | 1.9% |
| Enterprise Value (EV) 1 | 1,488 | 1,667 |
| Change | - | 12.01% |
| P/E | 12.4x | 11.5x |
| PBR | 2.05x | 1.77x |
| PEG | -5.93x | 1.2x |
| Capitalization / Revenue | 1.61x | 1.53x |
| EV / Revenue | 1.43x | 1.49x |
| EV / EBITDA | 8.44x | 9.06x |
| EV / EBIT | 8.75x | 9.49x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Dividend per Share 2 | - | - |
| Rate of return | - | - |
| EPS 2 | 8.279 | 9.07 |
| Distribution rate | - | - |
| Net sales 1 | 1,040 | 1,118 |
| EBITDA 1 | 176.3 | 183.9 |
| EBIT 1 | 170 | 175.7 |
| Net income 1 | 135.7 | 148.7 |
| Net Debt 1 | -190.8 | -44 |
| Reference price 2 | 102.45 | 104.40 |
| Nbr of stocks (in thousands) | 16,387 | 16,387 |
| Announcement Date | 04/09/25 | 13/09/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 15.66M | |
| 32.45x | 11.78x | 23.93x | 0.61% | 1,019B | |
| 28.48x | 6.32x | 17.74x | 2.09% | 617B | |
| 33.26x | 7.78x | 16.08x | 2.64% | 464B | |
| 104.98x | 5.87x | 24.89x | 2.36% | 356B | |
| 18.81x | 4.58x | 11.36x | 2.9% | 333B | |
| 19.83x | 5.17x | 12.78x | 3.09% | 267B | |
| 20.02x | 4.17x | 11.86x | 2.13% | 244B | |
| 25.46x | 6.66x | 11.86x | 2.5% | 218B | |
| -43.78x | 6.39x | 24.97x | 2.27% | 179B | |
| Average | 26.61x | 6.52x | 17.28x | 2.29% | 369.72B | |
| Weighted average by Cap. | 31.80x | 7.61x | 18.61x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- QUESTLAB Stock
- Valuation Quest Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
